Moreover, COVID-19 could have been an additional limiting factor to the utilization of higher dulaglutide doses
Serum icodec concentrations were measured (following IcoSema and icodec administration) using a validated luminescence oxygen channelling immunoassay (LOCI)
Missing doses or doubling up disrupts the steady-state concentrations these peptides need for optimal appetite suppression and metabolic effects
Retatrutide is an investigational triple receptor agonist developed by Eli Lilly that simultaneously targets three distinct hormonal receptors involved in energy regulation and metabolic control
The severe side effects of IV glutathione use have led the FDA of the Philippines to issue a public warning about the unsafe use of glutathione as a skin-lightening agent
The SUSTAIN-6 CVOT [67], performed in 3,297 patients with T2DM and ASCVD/CKD, has shown that compared to placebo, semaglutide was associated with increased retinopathy complications (3.0% versus 1.8%